News
EspeRare partners its XLHED program with Pierre Fabre | EspeRare...
esperare.org
EspeRare has entered into a partnership with the Pierre Fabre group to develop ER004, a novel in utero protein replacement therapy for the treatment of ...
sortiert nach Relevanz / Datum